FMO5 and Parkinson disease: Earlier studies postulated that NADPH oxidase and iNOS are not expressed in normal CNS conditions, but in PD patients and in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) intoxicated mice.